Cadmium is a human carcinogen with unfavorable health impact probably associated with its DNA methylation property. Recent data suggest that environmental cadmium exposure is associated with incidence of myocardial infarction and peripheral arterial disease. Nonetheless, the effect of chronic cadmium exposure on cardiac contractile function remains elusive.
This study was designed to examine the impact of low-dose cadmium exposure on cardiac contractile function and intracellular Ca2+ homeostasis. Adult male mice were exposed to cadmium for 4 weeks with or without the DNA methylation inhibitor (5-aza-2’-deoxyctidene, 5-AZA). Cardiac contractile and intracellular Ca2+ properties were analyzed including echocardiographic left ventricular parameters, fractional shortening (FS), peak shortening amplitude (PS), maximal velocity of shortening/relengthening (± dL/dt), time-to-PS (TPS), time-to-90% relengthening (TR90), electrically-stimulated increase of intracellular Ca2+ and intracellular Ca2+ decay.
Our results revealed that cadmium exposure depressed FS, PS, ± dL/dt and electrically-stimulated rise in intracellular Ca2+ without affecting TPS, TR90, intracellular Ca2+ level and decay rate, the effects of which were significantly attenuated or nullified by 5-AZA. Cadmium exposure led to overt interstitial fibrosis (collagen deposition), the effect of which was mitigated by 5-AZA. Western blot analysis showed unchanged expression of ICAM-1, TNF-α and Cleaved caspase-3 in response to cadmium exposure and/or 5-AZA treatment, suggesting a relatively minor role of pro-inflammatory cytokines and apoptosis in cadmium- and 5-AZA-induced cardiac responses.
Taken together, our data demonstrated for the first time direct cardiac depressant effect following cadmium exposure, which may be rescued by DNA methylation inhibition.